Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 79.79% is 301% above its 3-year average of 19.91%, near the low end of its 3-year range (0.00%–1524.69%).
As of the fiscal period ended Tuesday, June 30, 2026. 121.04% above its 12-month average of 36.10%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 79.79%.
DEBT TO ASSETS RATIO
79.79%
DEBT TO ASSETS RATIO AVG TTM
36.10%
DEBT TO ASSETS RATIO AVG 3Y
19.91%
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+121.04%
CURRENT VS 3Y AVG
+300.79%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 866 covered companies
CURRENT VS SECTOR MEDIAN
+88559.58%
vs the sector median at left
Medicus Pharma Ltd. Common Stock
Market Cap
$10.08M
Debt to Assets Ratio
79.79%
TTM Avg
36.10%
3Y Avg
19.91%
5Y Avg
N/A
Market Cap
$10.31M
Debt to Assets Ratio
0.61%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.37M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.66M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.51M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $10.08M | 79.79% | 36.10% | 19.91% | N/A |
| MetaVia Inc. (MTVA)vs › | $9.98M | 0.01% | N/A | N/A | N/A |
| Valion Bio, Inc. (VBIO)vs › | $10.19M | 0.54% | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.26M | 0.32% | N/A | N/A | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.31M | 0.61% | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.37M | 0.00% | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.68M | 0.71% | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | 0.01% | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | 0.06% | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.56M | 0.00% | N/A | N/A | N/A |
Debt/Assets
79.8%
Debt/Equity
N/A
Current Ratio
1.57
Interest Coverage
-129.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 79.79% |
| 2026-03-31 | 2.28% |
| 2025-12-31 | 54.44% |
| 2025-09-30 | 2.37% |
| 2025-06-30 | 41.61% |
| 2025-03-31 | 5.21% |
| 2024-12-31 | 5.71% |
| 2024-09-30 | 6.10% |
| 2024-06-30 | 4.27% |
| 2024-03-31 | 37.13% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 1524.69% |
